Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II

Mucopolysaccharidosis I and II are lysosomal storage disorders that, despite treatment with hematopoietic cell transplantation (HCT) and/or enzyme replacement therapy (ERT), continue to cause significant skeletal abnormalities leading to pain, stiffness, physical dysfunction, and short stature. Tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Polgreen, Lynda E., Kunin-Batson, Alicia, Rudser, Kyle, Vehe, Richard K., Utz, Jeanine J., Whitley, Chester B., Dickson, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238608/
https://www.ncbi.nlm.nih.gov/pubmed/28119823
http://dx.doi.org/10.1016/j.ymgmr.2017.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238608/
https://www.ncbi.nlm.nih.gov/pubmed/28119823
http://dx.doi.org/10.1016/j.ymgmr.2017.01.002

Ejemplares similares